Related Experiment Video
Updated: Sep 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Vaccines in the prevention of viral pneumonia
1Department of Internal Medicine, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
Abstract:
Vaccines to control respiratory virus infections have been limited to inactivated whole virus or split virus product of influenza. Over the last few years, advances in the understanding of immunity to and importance of these infections has led to the development of newer, more immunogenic inactivated influenza vaccines and to the exploration of live attenuated influenza vaccines. In parallel, both inactivated and live attenuated vaccines against respiratory syncytial virus and parainfluenza virus have been undergoing evaluation. More effective or new vaccines could reduce morbidity, reduce the frequency of hospitalization, and decrease the death rate. Since viral respiratory disease would be decreased in frequency, vaccines could reduce the use of antibiotics, and by so doing, preserve the usefulness of our currently available antibiotics.
Related Concept Videos
Vaccinations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
Pneumonia I: Introduction

